BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 19, 2006
View Archived Issues
Preclinical and clinical antithrombotic efficacy of rivaroxaban reported
Read More
Sequencing of human breast and colorectal cancers provides novel targets for drug design
Read More
AMD-3100 and G-CSF mobilize angiogenic cells, show wide clinical application
Read More
NovaDel Pharma adds oral spray drug development candidates to pipeline
Read More
Juvaris awarded SBIR grant for biodefense work
Read More
Anthera secures funding for novel secretory phospholipase programs
Read More
GSK reports on another successful quarter
Read More
Stem Cell Therapeutics options EPO programs in schizophrenia and MS
Read More
Phase IIa study of microplasmin in vitrectomy completes treatment
Read More
NuCana signs agreement with Cardiff ProTides to develop novel cancer agents
Read More
Bill & Melinda Gates Foundation supports efforts in hookworm and leishmaniasis
Read More
NV-1020 shows efficacy in liver metastases study
Read More
SQ-109 to begin clinical testing for tuberculosis
Read More
AstraZeneca and Schering to codevelop novel SERD for breast cancer
Read More
Phase II trial evaluates MGCD-0103 in relapsed or refractory B-cell lymphomas
Read More
Amgen presents novel TRPV1 antagonists with antinociceptive efficacy
Read More
SCV-07 shows oral bioavailability
Read More
Results for CTI-01 in cardiac surgery patients
Read More
Ginkgo biloba extract effective against postsurgical hypersensitivity
Read More
Efficacy of aliskiren/ramipril combination shown in hypertensive diabetic patients
Read More
Safety of ruboxistaurin in diabetic complications: results from 11 phase II and III trials
Read More
Antidiabetic efficacy of the DPP-IV inhibitor MP-513 shown in Zucker fatty rats
Read More
FDA approves first antifungal agent for prevention of IFIs caused by Aspergillus
Read More
Amgen reveals novel ACK1 inhibitors as anticancer candidates
Read More
Glivec approved in E.U. for additional cancer indications
Read More
Lyrica indications broadened in E.U. to include central neuropathic pain
Read More
Protherics seeks approval in U.S. for Voraxaze
Read More
Novel agents claimed for use in arthritis and other inflammatory disorders
Read More
Antipsoriatic agents prepared and tested at Relivia
Read More
New therapeutic agents for respiratory disorders revealed
Read More
Pfizer reports on promising anticancer development of new RTK inhibitor
Read More